Journals / Akademik Gastroenteroloji Dergisi / 2005 / Cilt: 4 - Sayı: 1

Comparison of the patients with diffuse antral and multifocal atrophic gastritis for gastric juice ascorbic acid levels and epithelial cell proliferations

Diffüz antral gastrit ve multifokal atrofik gastritli hastalarda mide sıvısı askorbik asit düzeyleri ve epitel hücre proliferasyonlarının karşılaştırılması

Pages
7–12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Immunohistochemical examination revealed that staining for cytokeratin- 20 was significantly less in MAG patients than in those with DAG (74.7% vs 90.9%, respectively; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Diffuse antral gastritis (DAG) is a duodenal ulcer phenotype of chronic Helicobacter pylori gastritis, while multifocal atrophic gastritis (MAG) is a gastric cancer phenotype.
📊
Key Findings & Data:The aim of this study was to investigate ascorbic acid (vitamin C) levels in the gastric juice in patients with DAG and MAG, to compare the gastric epithelial cell proliferation rates between the groups and also to examine any correlation between ascorbic acid levels in gastric juice and the cell proliferation rates.
💡
Conclusion & Impact:Immunohistochemical examination revealed that staining for cytokeratin- 20 was significantly less in MAG patients than in those with DAG (74.7% vs 90.9%, respectively; p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Askorbik asit · H. pylori · kronik gastrit

Abstract

Background/aim: Diffuse antral gastritis (DAG) is a duodenal ulcer phenotype of chronic Helicobacter pylori gastritis, while multifocal atrophic gastritis (MAG) is a gastric cancer phenotype. The aim of this study was to investigate ascorbic acid (vitamin C) levels in the gastric juice in patients with DAG and MAG, to compare the gastric epithelial cell proliferation rates between the groups and also to examine any correlation between ascorbic acid levels in gastric juice and the cell proliferation rates. Materials and methods: Thirty-seven patients with chronic H. pylori gastritis (27 MAG, 10 DAG) were included in the study (male/female: 15/22, range: 19-74, mean age: 43.6 yrs). Ascorbic acid concentrations in fasting plasma and gastric juice samples of the patients were measured. Loss of maturation in foveolar epithelium due to cell proliferation was shown immunohistochemically using cytokeratin-20 antibody in antral and corporal regions of both patient groups. Results: There was no significant difference in plasma ascorbic acid levels between the two groups. No statistically significant difference could be demonstrated in gastric juice ascorbic acid concentrations between patients with DAG and MAG (0.93±0.97 mg/dl and 0.96±1.12 mg/dl, respectively; p>0.05). Immunohistochemical examination revealed that staining for cytokeratin- 20 was significantly less in MAG patients than in those with DAG (74.7% vs 90.9%, respectively; p

Özet

Giriş ve amaç: Diffüz antral gastrit (DAG), kronik Helicobacter pylori gastritinin duodenal ülser fenotipini, multifokal atrofik gastrit (MAG) ise gastrik kanser fenotipini oluşturmaktadır. Bu çalışmada DAG ve MAG’lı olgularda gastrik sıvı askorbik asit düzeylerinin incelenmesi, grupların mide epitel hücre proliferasyon oranları açısından karşılaştırılması ve mide sıvısı askorbik asit (C vitamini) düzeyleriyle hücre proliferasyon oranları arasındaki olası korelasyonların araştırılması amaçlanmıştır. Gereç ve yöntem: H. pylori’ye bağlı 27 MAG, 10 DAG saptanan 37 hasta çalışmaya alındı (22 kadın, 15 erkek, 19-74, yaş ort: 43,6). Hastaların plazma ve gastrik sıvı örneklerinde askorbik asit düzeyleri ölçüldü. Olguların antrum ve korpuslarında hücre proliferasyonundan dolayı foveolar epiteldeki maturasyon kaybının varlığı, sitokeratin-20 (CK-20) antikoru kullanılarak immunohistokimyasal yöntemle gösterildi. Bulgular: Her iki grubun plazma askorbik asit düzeyleri arasında anlamlı farklılık yoktu. Gruplar, mide sıvısı askorbik asit düzeyleri açısından karşılaştırıldığında istatistiksel anlamlı bir farklılık gözlenmedi (DAG ve MAG için sırasıyla; 0.93±0.97, 0.96±1.12mg/dl, p > 0.05) MAG grubunda CK-20 için boyanma yüzdesi DAG grubundakilere göre anlamlı derecede düşüktü (%74.7 ve %90.9, p < 0.01). Boyanma yüzdeleriyle mide sıvısı askorbik asit değerleri arasında bir korelasyon saptanmadı. Sonuç: Bu çalışmada diffüz antral gastrit ve multifokal atrofik gastritli hastalar arasında mide sıvısı askorbik asit düzeyleri açısından anlamlı farklılık bulunmamıştır. Ancak, multifokal atrofik gastritin intestinal tip gastrik karsinogenez sürecinin proksimal aşamalarında yer aldığını destekleyecek şekilde, bu gastrit formunda epitel hücre proliferasyonunun artmış olduğu gösterilmiştir.

🔖

Cite This Article

AKBAKIR, N., DEMİRBAĞ, N., POTUROĞLU, Ş., ERGEN, K., KENDİR, M. (2005). Comparison of the patients with diffuse antral and multifocal atrophic gastritis for gastric juice ascorbic acid levels and epithelial cell proliferations. Akademik Gastroenteroloji Dergisi, Cilt: 4 - Sayı: 1, 7–12. https://ajindex.com/articles/196556

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kuipers EJ, Uyterlinde AM, Peña AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-28.
  2. Houghton J, Fox JG, Wang TC. Gastric cancer: laboratory bench to clinic. J Gastroenterol Hepatol 2002; 17: 495-502.
  3. Hansson L, Nyren O, Hsing A, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242-49.
  4. Faraji EI, Frank BB. Multifocal atrophic gastritis and gastric car- cinoma. Gastroenterol Clin North Am 2002; 31: 499-516.
  5. Ruiz B, Rood JC, Fontham ETH, et al. Vitamin C concentrations in gastric juice before and after anti Helicobacter pylori treatment. Am J Gastroenterol 1994; 89: 533-39.
  6. Banerjee S, Hawksby C, Miller S, et al. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994; 35: 317-22.
  7. Rokkas T, Papatheodorou G, Karameris A, et al. Helicobacter pylo- ri infection and gastric juice vitamin C levels. Impact of eradicati- on. Dig Dis Sci 1995; 40: 615-21.
  8. Cahill RJ, Kilgallen C, Beattie S, et al. Gastric epithelial cell kine- tics in the progression from normal mucosa to gastric carcinoma. Gut 1996; 38: 177-81.
  9. Houghton J, Macera-Bloch LS, Harrison L, et al. Tumor necrosis factor alpha and interleukin 1beta up-regulate gastric mucosal fas antigen expression in Helicobacter pylori infection. Infect Immun 2000; 68: 1189-95. de Freitas D, Urbano M, Goulao MH, et al. The effect of Helicobac- ter pylori infection on apoptosis and cell proliferation in gastric epithelium. Hepatogastroenterology 2004; 51: 876-82.
  10. De Luca A, De Falco M, Iaquinto S, et al. Effects of Helicobacter pylori infection on cell cycle progression and the expression of cell cycle regulatory proteins. J Cell Physiol 2004; 200: 334-42.
  11. Sobola G, Schorah C, Sanderson M, et al. Ascorbic acid in the hu- man stomach. Gastroenterology 1989; 97: 357-63. Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 1988; 83: 504-9.
  12. Sipponen P, Stolte M. Clinical impact of routine biopsies of the gast- ric antrum and body. Endoscopy 1997; 29: 671-8.
  13. Schwerer MJ, Kraft K, Baczako K. Structural changes in the gastric foveolar epithelium in Helicobacter pylori-positive gastritis revealed by keratin immunohistochemistry. Hum Pathol 1997; 28: 1260-7.
  14. Lauwers GY, Furman J, Michael LE, et al. Cytoskeletal and kinetic epithelial differences between NSAID gastropathy and Helicobacter pylori gastritis: an immunohistochemical determination. Histopat- hology. 2001;